Ascentage Pharma Group International (HKG:6855)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
33.60
-1.18 (-3.39%)
Aug 20, 2026, 4:09 PM HKT

HKG:6855 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1,469-1,243-405.43-925.64-882.92-782.42
Depreciation & Amortization
85.2285.2291.0790.8160.9227.53
Other Amortization
1.261.262.12.3920.8
Loss (Gain) From Sale of Assets
-0.67-0.67-0.04-0-2.270.03
Loss (Gain) From Sale of Investments
1.131.130.830.79.7720.89
Loss (Gain) on Equity Investments
-0.31-0.310.28-1.080.28-
Stock-Based Compensation
20.8720.8720.9231.522.1146.97
Other Operating Activities
181.45104.6467.9484.3931.81-108.13
Change in Accounts Receivable
-169.8-169.862.75-91.54-0.39-53.97
Change in Inventory
-26.2-26.29.57-6.72-5.52-3.93
Change in Accounts Payable
14.7714.7719.52-23.1124.747.5
Change in Unearned Revenue
-36.49-36.494.0982.98-24.66227.39
Change in Other Net Operating Assets
74.274.215.0429.24110.28-17.01
Operating Cash Flow
-1,323-1,174-111.36-726.08-653.92-604.68
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-19.39-27.57-24.29-46.11-203.29-435.42
Sale of Property, Plant & Equipment
0--0.012.350.34
Cash Acquisitions
--43.34-9.52-20-20-20
Sale (Purchase) of Intangibles
----10.74-33.68-1.21
Investment in Securities
654.3-929.14-328.2398.75-130-10.23
Investing Cash Flow
634.91-1,000-362.0421.92-384.61-466.52

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-1,241535.92953.5763.62599.74
Long-Term Debt Repaid
--933.71-681.26-966.86-67.74-60.24
Net Debt Issued (Repaid)
368.48307.26-145.34-13.36695.87539.5
Issuance of Common Stock
1,3552,305533.95470.090.021,197
Repurchase of Common Stock
-7.66-9.04--5.92-26.78-25.87
Other Financing Activities
-52.49-63.04-73.84-82.06-49.8570.97
Financing Cash Flow
1,6632,540314.77368.75619.271,781

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-111.16-63.2413.6827.8158.01-23.28
Net Cash Flow
863.55302.68-144.95-307.59-361.25686.91

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1,343-1,202-135.65-772.19-857.2-1,040
Free Cash Flow Growth
------
Free Cash Flow Margin
-208.93%-209.31%-13.83%-347.86%-408.75%-3726.60%
Free Cash Flow Per Share
-3.61-3.37-0.45-2.73-3.25-4.08
Levered Free Cash Flow
-974.3-942.63-81.25-706.12-680.98-954.65
Unlevered Free Cash Flow
-941.13-908.84-40.96-646.09-647.99-944.19

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
51.3151.3160.5692.3549.8516.81
Cash Income Tax Paid
0.030.03---3.85
Change in Working Capital
-143.5-143.5110.97-9.15104.41189.65